Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001649094-26-000043
Filing Date
2026-08-05
Accepted
2026-08-05 16:13:04
Documents
66
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcvx-20260630.htm   iXBRL 10-Q 1536016
2 EX-31.1 exhibit311q22026.htm EX-31.1 11349
3 EX-31.2 exhibit312q22026.htm EX-31.2 11490
4 EX-32.1 exhibit321q22026.htm EX-32.1 6394
  Complete submission text file 0001649094-26-000043.txt   6942091

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20260630.xsd EX-101.SCH 49832
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcvx-20260630_cal.xml EX-101.CAL 69200
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcvx-20260630_def.xml EX-101.DEF 219250
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20260630_lab.xml EX-101.LAB 632043
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20260630_pre.xml EX-101.PRE 411869
70 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20260630_htm.xml XML 823409
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39323 | Film No.: 261243669
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)